Biomarkers Drive Advances In Drug Therapy - Massive Bio

Biomarkers Drive Advances In Drug Therapy

Biomarkers Drive Advances In Drug Therapy - Massive Bio

Massive Bio, the company co-founded by Loaiza-Bonilla, for which he serves as Chief Medical Advisor, is helping to advance the field of precision oncology from a patient perspective with its Synergy AI registry, and is collaborating with pharmaceutical companies and healthcare providers to improve education about biomarkers and clinical trial matching. This registry combines genomic/biomarker data with artificial intelligence techniques to remove barriers to access and help justify the cost/benefits to diagnostics and therapeutics, with a major emphasis in clinical trial matching and virtual tumor boards.

Massive Bio has onboarded over 160,000+ cancer patients to find their clinical trial
See if you pre-qualify for clinical trials.

Our specialized team will contact you within 24 hours.

[EN] Blog Details - United States & Canada - English

Your Birthday



By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

See if you pre-qualify for clinical trials.

Our specialized team will contact you within 24 hours.

[EN] Blog Details - United States & Canada - English

Your Birthday



By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

Most Popular